Medical treatment of stable angina: A tailored therapeutic approach

Athanasios J. Manolis, Leonidas E. Poulimenos, Giuseppe Ambrosio, Manolis S. Kallistratos, Jose Lopez-Sendon, Ralf Dechend, Giuseppe Mancia, A. John Camm

Research output: Contribution to journalReview articlepeer-review


Treatment of stable angina is often challenging. In spite of several therapeutic approaches, many of these patients still have symptoms, which inevitably affect their daily activity and quality of life. Current ESC guidelines suggest an algorithm for the medical treatment of stable angina categorizing antianginal drugs as first- or second-line therapy, and then providing little suggestions to guide choice within each step. However, several questions emerge: Is there evidence for such an approach? Is there a true difference between first and second-line drugs in terms of prognosis and symptom relief? Is it possible to individualize patients and tailor treatment according to their comorbidities or risk factors? The purpose of this review is to summarize the evidence behind stable angina treatment recommendations, and to suggest a systematic therapeutic approach tailored to patients' cardiovascular profile, risk factors, and comorbidities.

Original languageEnglish
Pages (from-to)445-453
Number of pages9
JournalInternational Journal of Cardiology
Publication statusPublished - Oct 1 2016


  • Angina drugs
  • Prognosis
  • Stable angina
  • Symptom relief

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Medical treatment of stable angina: A tailored therapeutic approach'. Together they form a unique fingerprint.

Cite this